Sports / Entertainment

Shrink Nanotechnologies Unveils Product Image Of Initial StemDisc450 Prototype
Shrink Nanotechnologies, Inc. (“Shrink”) (OTC Bulletin Board: INKN), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450™, a high-yield, low cost, patent-pending cell …

Read more on Medical News Today

BIO Announces Initial Companies Selected to Present at the Inaugural BIO India International Partnering Conference
WASHINGTON–(BUSINESS WIRE)–The Biotechnology Industry Organization (BIO) today announced initial companies selected through a competitive screening process to present at the inaugural BIO India International Partnering Conference. “Our distinguished Advisory Committee recommended these companies because they represent significant investment opportunities based on their promising innovative …

Read more on Business Wire

Product Description
This digital document is an article from San Diego Business Journal, published by Thomson Gale on July 16, 2007. The length of the article is 1001 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Mergers, acquisitions leading ‘exit strategy’ for biotech companies: investors: initial public offerings not always best way to cash out.
Author: Katie Weeks
Publication: San Diego Business Journal (Magazine/Journal)
Date: July 16, 2007
Publisher: Thomson Gale
Volume: 28 Issue: 29 Page: 1(2)

Distributed by Thomson Gale

Mergers, acquisitions leading ‘exit strategy’ for biotech companies: investors: initial public offerings not always best way to cash out.: An article from: San Diego Business Journal